Capstone Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$3.57M Sell
74,472
-7,725
-9% -$369K 0.1% 240
2017
Q1
$3.72M Buy
82,197
+4,635
+6% +$197K 0.1% 232
2016
Q4
$3.14M Buy
77,562
+360
+0.5% +$14.2K 0.09% 265
2016
Q3
$2.95M Buy
77,202
+320
+0.4% +$12.8K 0.08% 285
2016
Q2
$3.22M Buy
76,882
+3,290
+4% +$135K 0.1% 249
2016
Q1
$2.96M Sell
73,592
-180
-0.2% -$7.23K 0.09% 289
2015
Q4
$3.15M Buy
73,772
+6,717
+10% +$309K 0.09% 278
2015
Q3
$3.18M Buy
67,055
+376
+0.6% +$19.1K 0.1% 258
2015
Q2
$3.3M Buy
66,679
+1,040
+2% +$52.7K 0.1% 276
2015
Q1
$3.25M Buy
65,639
+9,446
+17% +$452K 0.09% 271
2014
Q4
$2.56M Buy
56,193
+3,394
+6% +$165K 0.07% 309
2014
Q3
$2.98M Sell
52,799
-1,530
-3% -$82.2K 0.1% 243
2014
Q2
$2.89M Buy
54,329
+1,340
+3% +$71.1K 0.09% 259
2014
Q1
$2.77M Sell
52,989
-560
-1% -$28.3K 0.08% 276
2013
Q4
$2.87M Buy
53,549
+3,860
+8% +$199K 0.08% 275
2013
Q3
$2.52M Buy
49,689
+4,302
+9% +$219K 0.06% 366
2013
Q2
$2.34M Buy
+45,387
New +$2.42M 0.06% 360

Other funds holding SNY

Capstone Asset Management's SNY Position: Q2 2017 in Review

Capstone Asset Management reduced its Sanofi (SNY) stake by 9.4% in Q2 2017, selling an estimated $369K and leaving 74,472 shares worth $3.57M. The position accounts for 0.1% of the portfolio, ranked #240.

Capstone Asset Management first reported a position in SNY in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.72M in Q1 2017. 474 funds tracked by Wall St. Rank hold SNY as of Q2 2017.

  • Capstone Asset Management held 74,472 shares of Sanofi worth $3.57M as of Q2 2017.
  • Capstone Asset Management sold 7,725 Sanofi shares in Q2 2017, an estimated $369K.
  • Sanofi made up 0.1% of Capstone Asset Management's portfolio in Q2 2017, its #240 holding.
  • Capstone Asset Management first reported a position in Sanofi in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Sanofi position peaked at $3.72M in Q1 2017.
  • 474 funds tracked by Wall St. Rank held Sanofi as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.